2022 Life Sciences and Health Care Horizons
We increasingly encounter research and Development collaboration partners relying On various research tools, cell lines, and other Technologies to…
Source: lexology.com
Page 15 - Complete Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Complete Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Complete Response Today - Breaking & Trending Today
BEAM THERAPEUTICS INC. : Other Events (form 8-K)
Item 8.01 Other Events. As previously announced, Beam Therapeutics Inc. was informed on July 29, 2022, via e-mail communication from the U.S. Food and Drug Administration , that the BEAM-201... | August 30, 2022
Source: marketscreener.com
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2022 Financial Results
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today provided a corporate update and reported financial results for the second quarter ended June 30,...
Source: pharmiweb.com
Spero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business Update
10.08.2022 - Initiation of a Placebo-controlled Phase 2 Trial of SPR720 in Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Expected in 4Q 2022 Initiation of a Phase 2 Cross-indication Resistant Pathogen Trial of SPR206 Expected in 3Q 2023 Continued ...
Source: wallstreet-online.de
Caladrius Biosciences and Cend Therapeutics Announce Publication of Pancreatic Cancer Trial Data in The Lancet Gastroenterology and Hepatology
BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 -- Caladrius Biosciences, Inc. , a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse... | July 6, 2022
Source: marketscreener.com